Literature DB >> 9764597

Macrophage function in alloxan diabetic mice: expression of adhesion molecules, generation of monokines and oxygen and NO radicals.

W Ptak1, M Klimek, K Bryniarski, M Ptak, P Majcher.   

Abstract

The increased incidence of bacterial and mycotic infections in poorly controlled diabetic patients or animals is frequently attributed to impaired activities of professional phagocytes (granulocytes, macrophages) in hypoinsulinaemic milieu. We measured production of monokines (IL-6 and tumour necrosis factor-alpha (TNF-alpha)), active NO and reactive oxygen intermediates (ROIs), as well as expression of several cell surface adhesion molecules (Mac-1, -2 and -3, intercellular adhesion molecule-1 (ICAM-1) and Fc gammaRII), by thioglycollate medium-induced peritoneal macrophages of normoglycaemic and alloxan diabetic CBA/J mice (blood glucose level in the range 300 or 500 mg/dl). Macrophages of animals with moderate diabetes (300 mg/dl) produced significantly more IL-6 and TNF-alpha and ROIs than cells of control mice and showed an increased expression of all cell surface molecules, except Mac-3. NO/NO2 production was not affected. Administration of insulin restored enhanced values to normal levels, except for the production of ROIs which remained unusually high. We conclude that two separate mechanisms influence macrophage physiology in diabetes--lack of saturation of insulin receptors on macrophages and an indirect effect due to formation of advanced glycosylation endproducts (AGE) on their surfaces. The latter is possibly responsible for increased generation of ROIs, since it cannot be down-regulated by prolonged insulin treatment. How the increased activity of macrophages of moderately diabetic mice (enhanced production of proinflammatory monokines and oxygen radicals as well as expression of molecules) is related to their ability to kill bacteria is now under investigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764597      PMCID: PMC1905080          DOI: 10.1046/j.1365-2249.1998.00687.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Alterations in monocyte receptor function in type 1 diabetic patients with ketoacidosis.

Authors:  J Stewart; A Collier; A W Patrick; B F Clarke; D M Weir
Journal:  Diabet Med       Date:  1991-04       Impact factor: 4.359

2.  Activated human monocytes exhibit receptor-mediated adhesion to a non-enzymatically glycosylated protein substrate.

Authors:  M Z Gilcrease; R L Hoover
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

3.  Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.

Authors:  M J Hussain; M Peakman; H Gallati; S S Lo; M Hawa; G C Viberti; P J Watkins; R D Leslie; D Vergani
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

4.  Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus.

Authors:  A Mowat; J Baum
Journal:  N Engl J Med       Date:  1971-03-25       Impact factor: 91.245

5.  Expression of a soluble and functional form of the human beta 2 integrin CD11b/CD18.

Authors:  N Dana; D M Fathallah; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocin-induced diabetic rats.

Authors:  M Masuda; T Murakami; H Egawa; K Murata
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

7.  Respiratory burst in alveolar macrophages of diabetic rats.

Authors:  V Mohsenin; J Latifpour
Journal:  J Appl Physiol (1985)       Date:  1990-06

Review 8.  Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues.

Authors:  H Vlassara
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

Review 9.  Fc-receptor-mediated phagocytosis: abnormalities associated with diabetes mellitus.

Authors:  C K Abrass
Journal:  Clin Immunol Immunopathol       Date:  1991-01

10.  In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6.

Authors:  J Marcinkiewicz
Journal:  Cytokine       Date:  1991-07       Impact factor: 3.861

View more
  7 in total

1.  Impaired inflammatory responses to multiple toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice.

Authors:  Hideaki Yamasawa; Masayuki Nakayama; Masashi Bando; Yukihiko Sugiyama
Journal:  Inflamm Res       Date:  2012-01-07       Impact factor: 4.575

2.  Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions.

Authors:  Haibin Tian; Yan Lu; Shraddha P Shah; Song Hong
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

3.  OGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbance.

Authors:  Yunfan Yang; Xiruo Li; Harding H Luan; Bichen Zhang; Kaisi Zhang; Jin Hyun Nam; Zongyu Li; Minnie Fu; Alexander Munk; Dongyan Zhang; Simeng Wang; Yuyang Liu; João Paulo Albuquerque; Qunxiang Ong; Rui Li; Qi Wang; Marie E Robert; Rachel J Perry; Dongjun Chung; Gerald I Shulman; Xiaoyong Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

4.  Increased recruitment but impaired function of leukocytes during inflammation in mouse models of type 1 and type 2 diabetes.

Authors:  Ulrika Sofia Pettersson; Gustaf Christoffersson; Sara Massena; David Ahl; Leif Jansson; Johanna Henriksnäs; Mia Phillipson
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

5.  Effect of hochuekkito on alveolar macrophage inflammatory responses in hyperglycemic mice.

Authors:  Masayuki Nakayama; Yukihiko Sugiyama; Hideaki Yamasawa; Manabu Soda; Naoko Mato; Tatsuya Hosono; Masashi Bando
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

Review 6.  O-GlcNAcylation and Inflammation: A Vast Territory to Explore.

Authors:  Léa Baudoin; Tarik Issad
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-09       Impact factor: 5.555

7.  Dioscin attenuates oxLDL uptake and the inflammatory reaction of dendritic cells under high glucose conditions by blocking p38 MAPK.

Authors:  Ying Li; Yong Li; Te Yang; Ming Wang
Journal:  Mol Med Rep       Date:  2019-11-06       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.